Product Program year 2020 Source: CMS Open Payments

HeartMate II LVAS

Device Cardiac Arrhythmias and Heart Failure

Open in the dashboard

General payments

$61,388

228 payments

Research payments

$2,534

98 payments

Through program year 2020, $61,388 in general payments and $2,534 in research payments were reported against HeartMate II LVAS (Cardiac Arrhythmias and Heart Failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $8,312 15
2020 Research $54 2
2019 General $53,076 213
2019 Research $2,480 96

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $61,388 228 payments
Top recipients General payments · program year 2020
  1. Hao Tran Advanced Heart Failure and Transplant Cardiology · San Diego, CA $6,496 78% · 3 payments
  2. Liviu Klein Advanced Heart Failure and Transplant Cardiology · San Francisco, CA $1,375 17% · 3 payments
  3. Aldo Rafael-Yarihuaman Thoracic Surgery (Cardiothoracic Vascular Surgery) · Dallas, TX $142 2% · 1 payment
  4. Cesar Guerrero Cardiovascular Disease · Dallas, TX $142 2% · 1 payment
  5. Alexandra Tuluca Thoracic Surgery (Cardiothoracic Vascular Surgery) · Philadelphia, PA $49 <1% · 2 payments

The top 5 of 9 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Advanced Heart Failure and Transplant Cardiology Internal Medicine $7,906 95% · 3 practitioners
  2. Thoracic Surgery (Cardiothoracic Vascular Surgery) $238 3% · 4 practitioners
  3. Cardiovascular Disease Internal Medicine $142 2% · 1 practitioner
  4. Interventional Cardiology Internal Medicine $25 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. California $7,871 95% · 2 recipients
  2. Texas $343 4% · 4 recipients
  3. Pennsylvania $98 1% · 3 recipients

Each share is of general payments naming this product in 2020 where a state was reported.

228 general · 98 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record